Skip to main content

Topiramate Tablets

Type of Posting: Revision Bulletin

Posting Date: 27–Aug–2010

Official Date: 01–Oct–2010

Expert Committee: Monographs—Small Molecules 4

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 4 Expert Committee has revised the monograph for Topiramate Tablets. The purpose for the revision is to add Dissolution Test 2 and Dissolution Test 3 for products approved by FDA.

The Topiramate Tablets Revision Bulletin supersedes the currently official Topiramate Tablets monograph. The Revision Bulletin will be incorporated into the First Supplement to USP 34–NF 29.

Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or MRM@usp.org).